PAA 7.69% 21.0¢ pharmaust limited

Ann: Final MND Patient in Cohort 4 Successfully Completes Dosing, page-126

  1. 2,861 Posts.
    lightbulb Created with Sketch. 1051
    Actually the PAA BoD was preaching to its SH masses who were growing hungry and agitated for those previously preached imminent results, but all PAA had was Roger who morphed into Dr MT. who announced the licensing out of MPL for canine cancer and a commercial partner for the future trialing and development of MPL for MND and human cancers with a "s". The masses returned to their caves duly satiated.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.